Alexxai Kravitz is associate professor of psychiatry at Washington University in St. Louis, where he leads a team of researchers that focuses on understanding how the brain mediates feeding and obesity in mice. In addition to a passion for understanding feeding, his lab has a strong interest in developing open-source hardware devices to study rodent behavior, and in adopting open-science practices for neuroscience research.
Alexxai Kravitz
Associate professor of psychiatry
Washington University in St. Louis
From this contributor
Unleashing the power of DIY innovation in behavioral neuroscience
Widespread adoption of open-source tools calls for more support and training.
Unleashing the power of DIY innovation in behavioral neuroscience
By
Alexxai Kravitz, Mark Laubach
2 April 2024 | 0 min watch
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
By
Calli McMurray
2 October 2025 | 10 min read
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
By
Brendan Borrell
1 October 2025 | 11 min read